UA Drug Research
September 30, 2010 in Imported by Bob Hagen
$1.1 million grant for drug development
30 September 2010
Inside Tucson Business
Blog
Innovative drug development research that could lead to the creation of new medications are under development by three University of Arizona researchers due to a new $1.1 million grant from the National Institutes of Health (NIH).
The three-year grant supports small molecule drug development advancements that could lead to new drugs for cancer, diabetes, and other diseases.
“Some of the benefits of drugs developed from small molecules are that they are stable, bio-available, less expensive to manufacture, and can be taken orally,” said lead UA researcher Christopher Hulme, Ph.D., professor of medicinal chemistry in the College of Pharmacy and a BIO5 member.
Under the grant, Hulme will collaborate with Victor Hruby, Ph.D., Regents’ Professor emeritus of chemistry in the College of Science and a BIO5 member; and Ruben Vardanyan, Ph.D., a research professor in the Department of Chemistry.


This week we’ve got a special treat for all of the creative people out there trying to get their ideas out in front of others. We welcome Sandy Williams to Innovators Mix to teach us the right way to handle marketing our great ideas. As always, please let us know what you think so we can alway bring you the best content!